Skip to main content
    T

    TuHURA Biosciences Inc (HURA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.40
    +0.07 (+5.26%)

    Market Cap: $84.76M

    Last updated: Nov 17, 2026 at 4:26 PM ET

    TuHURA Biosciences Inc (HURA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    TuHURA Biosciences (HURA) has a market cap of $84.76M and an enterprise value of $92.40M. Its share count is up 28.29% from a year earlier.

    Total Valuation

    Enterprise value is 9.02% above the market cap, as debt exceeds cash.

    Market Cap$84.76M
    Enterprise Value$92.40M
    Latest price (Nov 17, 2026)$1.40

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndJune

    Share Statistics

    The share count rose 1.62% in the quarter ended Sep 30, 2026.

    Shares Outstanding65.00M
    Shares Change (YoY)+28.29%
    Shares Change (QoQ)+1.62%

    Price Statistics

    The stock is down 31.71% over 52 weeks and trades 25.93% below its 50-day average.

    Beta (1Y)2.82
    52-Week Change-31.71%
    1-Month Change-21.35%
    3-Month Change-38.60%
    6-Month Change-43.09%
    5-Year Change-99.87%
    10-Year Change-100.00%
    Total Return (1Y)-31.71%
    Total Return (3Y CAGR)-52.18%
    Total Return (5Y CAGR)-74.78%
    Return vs SPY (1Y)-39.02%
    Max Drawdown (1Y)-78.95%
    Max Drawdown (3Y)-96.82%
    Sharpe Ratio (1Y)-0.26
    Correlation with SPY (1Y)0.31
    50-Day Average$1.89
    200-Day Average$2.03
    52-Week Range$0.41 to $3.43
    RSI (14 Days)34.6
    Average Volume (20 Days)601.32K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.47x current liabilities, and total debt is 0.50x shareholder equity.

    Current Ratio0.47x
    Quick Ratio0.47x
    Debt / Equity0.50x
    Interest Coverage-15.12x

    Returns and Efficiency

    Return on invested capital is -77.84% and return on equity is -157.96% over the last 12 months.

    Return on Equity (ROE)-157.96%
    Return on Assets (ROA)-82.61%
    Return on Invested Capital (ROIC)-77.84%
    Return on Capital Employed (ROCE)-98.55%

    Scores

    HURA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$30.13M
    Pretax Income-$29.93M
    Net Income-$29.94M
    EBITDA-$27.97M
    EBIT-$28.07M
    Reported EPS (TTM)-$0.53

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 52.29% of the $36.24M in total assets.

    Cash and Equivalents$1.89M
    Total Debt$9.54M
    Net Debt$7.65M
    Net Debt Per Share$0.12
    Working Capital-$4.07M
    Shareholder Equity$18.95M
    Book Value Per Share$0.29
    Tangible Book Value-$3.06M
    Total Assets$36.24M
    Total Liabilities$17.29M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Stock Splits

    The last split was a 1-for-35 reverse split on Oct 18, 2024.

    Last Split DateOct 18, 2024
    Split TypeReverse split
    Split Ratio1:35

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About HURA

    What is HURA's market cap?

    TuHURA Biosciences has a market cap of $84.76M. Its enterprise value, which adds debt and subtracts cash, is $92.40M.

    How many shares of HURA are outstanding?

    TuHURA Biosciences has 65.00M shares outstanding. The count is up 28.29% from a year earlier.

    Does HURA pay a dividend?

    No. TuHURA Biosciences does not pay a dividend.

    How much debt does HURA have?

    TuHURA Biosciences has $9.54M of total debt and $1.89M of cash and equivalents, a net debt position of $7.65M.